CH
Therapeutic Areas
China Resources Pharmaceutical Group Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Chemical Generics Portfolio | Various (Cardiovascular, CNS, Anti-infective) | Approved |
| Traditional Chinese Medicine Portfolio | Various Chronic Diseases & Wellness | Approved |
| Biosimilar Candidates | Oncology, Autoimmune Diseases | Phase 3 |
| Innovative Drug R&D Programs | Oncology, Metabolic Diseases | Phase 1/2 |
Leadership Team at China Resources Pharmaceutical Group
FY
Fu Yuning
Chairman of the Board
BX
Bai Xiaoming
Vice Chairman and Chief Executive Officer (CEO)
TQ
Tong Qiang
Executive Director and President
ZH
Zhou Hong
Chief Financial Officer (CFO)
WY
Wang Yuan
Executive Vice President
WZ
Wang Zhendong
Executive Vice President
MJ
Mou Jie
Executive Vice President